The Centers for Medicare & Medicaid Services Friday issued its calendar year 2023 proposed rule for the home health prospective payment system, which would reduce net HH payments by $810 million in calendar year 2023 relative to CY 2022. The rule also would strive to achieve budget-neutrality for the Patient-driven Groupings Model on a prospective basis through a 6.9 percentage point cut to all payments; and implement a 0.2% high-cost outlier cut. AHA said it was very concerned about the unprecedented scale of the proposed PDGM behavioral offset. In addition, the rule would require collection of all patient assessment data for the HH Quality Reporting Program; collect feedback on strategies to better measure disparities in health care outcomes; and change the terminology and timeline for baseline years used to calculate performance in the Value-based Purchasing program. CMS will accept comments on the proposed rule through Aug. 16. 

Headline
The Health Resources and Services Administration announced that 340B covered entities purchased $100 billion in outpatient drugs under the federal 340B Drug…
Perspective
Public
As we move into the second half of 2026 and Congress returns to work in Washington, D.C., next week, lawmakers face a list of difficult issues that demand…
Headline
Most hospital outreach laboratories have until July 31 to report required private payer clinical diagnostic laboratory data for services furnished during the…
Headline
The Centers for Medicare & Medicaid Services July 2 issued a proposed rule that would increase Medicare hospital outpatient prospective payment system…
Headline
The AHA provided comments June 9 to the Centers for Medicare & Medicaid Services on its proposed Comprehensive Care for Joint Replacement Expanded…
Headline
Eli Lilly said June 1 it will deny 340B Drug Pricing Program discounts to providers that do not meet its documentation requirements by next week.In a statement…